Abstract
Inescapable shock (IS) produces subsequent interference with escape behavior and increased fear conditioning that has been linked to increased activity and release of serotonin (5-HT) from neurons within the caudal dorsal raphe nucleus (DRN) both at the time of IS and later behavioral testing. Extrahypothalamic corticotropin-releasing hormone (CRH) has been implicated in many stress-related phenomena and has recently been shown to increase DRN 5-HT activity in the same caudal DRN area at which IS increases 5-HT activity. The current set of studies therefore examined the role of CRH in mediating the behavioral sequelae of IS. Intra-DRN microinjection of the nonselective CRH receptor antagonist d-Phe CRH (12-41) blocked the IS-induced behavioral changes when administered before IS but not when administered before later behavioral testing. Furthermore, intra-DRN administration of CRH in the absence of IS dose-dependently mimicked the effects of IS and interfered with escape behavior and increased fear conditioning 24 hr later. This effect was specific to injection of CRH into the caudal DRN and was not produced by microinjection into the rostral DRN. Intracerebroventricular CRH produced escape deficits and potentiated fear conditioning 24 hr later at only much higher doses, further confirming the site specificity of the effects. The potential role of the caudal DRN in states of anxiety is discussed.
MeSH Terms
Animals
Behavior, Animal/drug effects,physiology
Conditioning, Psychological/drug effects,physiology
Corticotropin-Releasing Hormone/administration & dosage,analogs & derivatives,antagonists & inhibitors,metabolism
Dose-Response Relationship, Drug
Electroshock
Escape Reaction/drug effects,physiology
Helplessness, Learned
Injections, Intraventricular
Male
Microinjections
Organ Specificity/drug effects
Raphe Nuclei/drug effects,metabolism
Rats
Rats, Sprague-Dawley
Reaction Time/drug effects
Receptors, Corticotropin-Releasing Hormone/antagonists & inhibitors
Stress, Physiological/physiopathology
Chemicals
Receptors, Corticotropin-Releasing Hormone
phenylalanyl corticotropin-releasing factor (12-41)
Corticotropin-Releasing Hormone
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Hammack Sayamwong E
Department of Psychology and Center for Neuroscience, University of Colorado at Boulder, Boulder, Colorado 80309-0345, USA.
Richey Kristen J
Schmid Megan J
LoPresti Matthew L
Watkins Linda R
Maier Steven F
References (28)
28 references, click to expand
-
Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat.
Brain Res. 1998 Nov 23;812(1-2):113-20
PMID: 9813270
-
In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.
Endocrinology. 1996 Dec;137(12):5747-50
PMID: 8940412
-
Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study.
J Neurosci. 1983 Jul;3(7):1355-68
PMID: 6345725
-
Effects of corticotropin-releasing factor on brain serotonergic activity.
Neuropsychopharmacology. 1998 Jun;18(6):492-502
PMID: 9571657
-
Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system.
J Neurosci. 2000 Oct 15;20(20):7728-36
PMID: 11027235
-
Conspectus. Corticotropin-releasing factor.
Compr Ther. 1985 Jun;11(6):3-5
PMID: 2990803
-
Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex.
J Neurosci. 1997 Aug 15;17(16):6434-46
PMID: 9236251
-
Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus.
J Comp Neurol. 2000 May 8;420(3):305-23
PMID: 10754504
-
8-OH-DPAT microinjected in the region of the dorsal raphe nucleus blocks and reverses the enhancement of fear conditioning and interference with escape produced by exposure to inescapable shock.
Behav Neurosci. 1995 Jun;109(3):404-12
PMID: 7662151
-
Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus.
J Comp Neurol. 2001 Jul 9;435(4):450-63
PMID: 11406825
-
Exposure to inescapable but not escapable shock increases extracellular levels of 5-HT in the dorsal raphe nucleus of the rat.
Brain Res. 1998 Feb 2;783(1):115-20
PMID: 9479059
-
Corticotrophin-releasing factor receptors: from molecular biology to drug design.
Trends Pharmacol Sci. 1996 Apr;17(4):166-72
PMID: 8984745
-
Escapable and inescapable stress differentially and selectively alter extracellular levels of 5-HT in the ventral hippocampus and dorsal periaqueductal gray of the rat.
Brain Res. 1998 Jun 22;797(1):12-22
PMID: 9630480
-
Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens.
Brain Res. 1993 Oct 8;624(1-2):188-98
PMID: 8252391
-
Differential distribution of corticotropin-releasing hormone immunoreactive axons in monoaminergic nuclei of the human brainstem.
Neuropsychopharmacology. 1997 Nov;17(5):326-41
PMID: 9348548
-
Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.
J Neurosci. 2001 Apr 15;21(8):2833-41
PMID: 11306635
-
A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat.
J Comp Neurol. 1991 Nov 22;313(4):643-68
PMID: 1783685
-
Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus.
Neuropsychopharmacology. 2000 Feb;22(2):148-62
PMID: 10649828
-
Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor.
Brain Res. 1999 Apr 24;826(1):35-43
PMID: 10216194
-
Is corticotropin-releasing factor a mediator of stress responses?
Ann N Y Acad Sci. 1990;579:183-91
PMID: 2186685
-
The role of the amygdala and dorsal raphe nucleus in mediating the behavioral consequences of inescapable shock.
Behav Neurosci. 1993 Apr;107(2):377-88
PMID: 8484901
-
Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods.
Neuroscience. 1998 Jan;82(2):443-68
PMID: 9466453
-
The dorsal raphe nucleus is a site of action mediating the behavioral effects of the benzodiazepine receptor inverse agonist DMCM.
Behav Neurosci. 1995 Aug;109(4):759-66
PMID: 7576219
-
The organization of divergent axonal projections from the midbrain raphe nuclei in the rat.
J Comp Neurol. 1986 Jan 15;243(3):363-80
PMID: 2419370
-
The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies.
Ciba Found Symp. 1993;172:296-308; discussion 308-16
PMID: 8491091
-
The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.
Endocrinology. 1999 Jan;140(1):79-86
PMID: 9886810
-
Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.
Eur J Pharmacol. 1997 Mar 26;323(1):21-6
PMID: 9105872
-
Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex.
J Neurosci. 1992 Jun;12(6):2313-20
PMID: 1607942